Check out this week's QuadCast as we discuss if PCV is better than TMZ for oligodendroglioma, discuss results of the hypo-FLAME trial for prostate cancer, highlight adjuvant RT for high risk bladder cancer in the BART trial, and more.
Check out the website and subscribe to the newsletter!
www.quadshotnews.com
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
